Received Oct 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUAD) | SEQIRUS, INC. | UNK | — | — |
Patient reports redness, swelling (excess of fluid build up) & "deep" pain at the injection site for 3 weeks following a Fluad injection. Patient received Fluad previously (Sept. 2023, Oct. 2024) without any side effects administered to patient 9/28/25. Report made 10/24/25 at the pharmacy.
Patient reports no known allergies.